Bausch + Lomb Corporation BLCO Q3 2025 Earnings Call

Q3 2025 Performance Overview

• 💡 The call provides an overview of Bausch + Lomb's impressive third quarter 2025 earnings and financial results.
• 🎯 Brent Saunders, Chairman and CEO, highlighted that the company's strategy and patience are yielding positive results.
• 🧠 Participants include George Gatkowski (VP of Investor Relations) and Sam Eldosuki (CFO), who will delve deeper into financials.

Key Financial Achievements

• 📈 The company reported 6% constant currency revenue growth for the quarter.
• 🚀 This growth was primarily fueled by a strong base business engine and the steady introduction of innovative products.
• 💰 Pharmaceuticals emerged as a standout performer, contributing significantly to overall results.

Product-Driven Growth

• ✅ Maybo revenue reached $84 million, which helped bolster the comprehensive dry eye portfolio.
• 👁️ Effective selling strategies led to more surgeons implanting InVista intraocular lenses.
• ✨ The InVista lenses contributed to 27% constant currency revenue growth in premium products.
• 🔬 The company emphasized its loaded and differentiated product pipeline as a future growth driver.

Important Disclosures

• ⚠️ The presentation contains forward-looking information and discusses non-GAAP financial measures.
• 📊 Financial guidance provided is effective as of today only and generally not updated until the following quarter, unless legally required.